1h Free Analyst Time
The publisher has been monitoring the breast cancer therapeutics market and it is poised to grow by $13.85 billion during 2022-2026, accelerating at a CAGR of 8.95% during the forecast period. This report on the breast cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
This report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of breast cancer, robust pipeline and new drug approvals, and rising number of patient support initiatives.
The breast cancer therapeutics market analysis includes the product segment and geographic landscape,
The publisher's breast cancer therapeutics market is segmented as below:
By Product
- Targeted therapy
- Hormonal therapy
- Chemotherapy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on the breast cancer therapeutics market covers the following areas:
- Breast cancer therapeutics market sizing
- Breast cancer therapeutics market forecast
- Breast cancer therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Exhibits:
Executive Summary
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes the publisher's platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- Clovis Oncology Inc.
- Daiichi Sankyo Co. Ltd.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Kyowa Kirin Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- PerkinElmer Inc.
- Pfizer Inc.
- Puma Biotechnology Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.